Author

V. Junco

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Ramiro· 1 shared A. V. Marin· 1 shared D. Ulgiati· 1 shared E. Molina· 1 shared I. Moreno de Alboran· 1 shared I. Varela· 1 shared J. C. Acosta· 1 shared J. Leon· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Ramiro

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

MYC directly transactivates CR2/CD21, the receptor of the Epstein-Barr virus, and enhances the viral infection of Burkitt lymphoma cells

E. Molina, L. Garcia-Gutierrez, V. Junco, M. Perez-Olivares, V. G de Yebenes, R. Blanco, L. Quevedo, J. C. Acosta, A. V. Marin, D. Ulgiati, R. Merino, I. Varela, J. R. Regueiro, I. Moreno de Alboran, A. Ramiro, J. Leon

This paper identifies CR2/CD21 as a direct target of MYC and shows that MYC enhances EBV infection in Burkitt lymphoma cells.

bioRxiv · Dec 28, 2022 · PreprintCancer Biology